Research Co. Inks $7.15M Deal To End Stock Plan Suit
A genomic research company agreed to pay $7.15 million to resolve a suit claiming it shorted former workers enrolled in an employee stock ownership plan when it required them to sell...To view the full article, register now.
Already a subscriber? Click here to view full article